NR4A1 and breast cancer: In conclusion, for premenopausal hormone receptor-positive BC patients, TAM endocrine therapy demonstrated significant short- and long-term protective effects on serum lipids, as evidenced by a gradual decrease in LDL-C levels and increased HDL-C levels with prolonged medication time.